F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$108.34M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.70M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	4,631
Open	39.83
Previous Close	39.72
Day's Range	39.83 - 40.58
52-Week Low	24.05
52-Week High	40.58
Beta	n/a
Holdings	41
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

55.49% of assets

Name	Symbol	Weight
Travere Therapeutics, Inc.	TVTX	7.76%
LivaNova PLC	LIVN	7.71%
Cogent Biosciences, Inc.	COGT	6.90%
Spyre Therapeutics, Inc.	SYRE	6.69%
Guardant Health, Inc.	GH	5.68%
Corcept Therapeutics Incorporated	CORT	5.50%
Mirum Pharmaceuticals, Inc.	MIRM	4.65%
United Therapeutics Corporation	UTHR	4.15%
Savara Inc.	SVRA	3.22%
Veradermics, Incorporated	MANE	3.22%

Performance

LFSC had a total return of 62.88% in the past year, including dividends. Since the fund's inception, the average annual return has been 34.12%.